Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the tacrolimus market grown in recent years?

The market size for tacrolimus has experienced robust growth recently. The prediction is an increase from $6.59 billion in 2024 to $7.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors attributing to the growth in the historical period include the evolution of transplantation medicine, a rise in organ transplant procedures, regulatory green lights, an extended use in dermatology, the widespread occurrence of autoimmune diseases, an upturn in research investments, and improved drug delivery technologies.

How is the tacrolimus market size expected to evolve during the forecast period?

The tacrolimus market size is expected to see strong growth in the next few years. It will grow to $9.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to expanded therapeutic applications, regulatory approvals for new indications, increased investment in research and development, growing awareness and acceptance of immunosuppressant therapies, expanding healthcare infrastructure in emerging markets, and evolving treatment guidelines and protocols. Major trends in the forecast period include increased adoption of personalized medicine approaches, advancements in drug delivery systems, expanding applications in autoimmune disorders, rising demand in emerging markets, growing emphasis on bioequivalence studies, development of novel formulations, and integration of pharmacogenomics for optimized dosing regimens.

Get your tacrolimus market report here!

https://www.thebusinessresearchcompany.com/report/tacrolimus-global-market-report

Which key drivers are propelling the tacrolimus market’s growth?

The tacrolimus market is poised for growth courtesy of the rising number of organ transplant procedures. Organ transplantation involves the surgical placement of a donor’s organ or tissue in a recipient to replace an organ that is no longer functional. Accelerating rates of organ transplantation can be attributed to the advancement in medical technology, improvements in surgical techniques, heightened consciousness about organ donation, and better post-transplantation care. Used in organ transplantation, tacrolimus works by thwarting T-cell activation and curbing cytokine production, which subsequently prevents the immune system from rejecting the transplanted organ. As per the US Department of Health and Human Services, a health service government administration in the US, in January 2024, organ transplantation from deceased and living donors totalled 46,632. This indicates an 8.7% increase compared to 2022 and a 12.7% rise against 2021 figures. Hence, the tacrolimus market is experiencing growth fuelled by the increasing organ transplant procedures.

What are the market segments in the tacrolimus industry?

The tacrolimus market covered in this report is segmented –

1) By Product Type: Tacrolimus Capsules And Tablets, Tacrolimus Ointment, Tacrolimus Injection, Tacrolimus Granules

2) By Application: Immunosuppression, Dermatitis, Other Applications

3) By End User: Organ Transplant Centers, Hospitals, Clinics, Other End Users

Subsegments:

1) By Tacrolimus Capsules And Tablets: Oral Capsules, Oral Tablets

2) By Tacrolimus Ointment: Topical Ointment (0.03%), Topical Ointment (0.1%)

3) By Tacrolimus Injection: Injectable Solution, Injectable Powder

4) By Tacrolimus Granules: Oral Granules (For Suspension)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15679&type=smp

What are the top market players propelling the growth of the tacrolimus industry?

Major companies operating in the tacrolimus market are Sinopharm Chuankang Pharmaceutical, F. Hoffmann-La Roche AG, Abbott Laboratories, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., Sandoz Inc., Huadong Medicine Co Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Wockhardt Limited, Biocon Ltd., Zydus Lifesciences Limited, Panacea Biotec, RPG Life Science, Sun Pharmaceutical Industries Limited, Tecoland Corporation

How are evolving market trends shaping tacrolimus Strategies?

Leading organisations in the tacrolimus market are crafting advanced drugs like tacrolimus ointments to suffice the increasing demand for innovative dermatological treatments and to uplift the level of patient care. Tacrolimus ointment serves as a skin-applied treatment composed of tacrolimus, an agent that suppresses the immune system, mainly used to address inflammatory skin ailments. To illustrate, Glenmark, a pharmaceutical company in India, procured approval from the United States Food and Drug Administration (US FDA) in August 2023 for their Tacrolimus Ointment 0.03%. This is a generic equivalent of Protopic Ointment 0.03%. The distribution of Tacrolimus Ointment, 0.03%, across the United States will be managed by Glenmark Pharmaceuticals. This drug is advised for patients suffering from moderate-to-severe atopic dermatitis, a skin disorder that prompts inflammation, redness, and itching.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15679

What regions are dominating the tacrolimus market growth?

North America was the largest region in the tacrolimus market in 2024 and 2024. The regions covered in the tacrolimus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Immuno-Oncology Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Nanotechnology-Based Medical Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nanotechnology-based-medical-devices-global-market-report

COVID-19 (COVID-19) Current Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: